Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Wayners who wrote (85)	8/13/2001 8:16:40 PM
From: keokalani'nui	Respond to of 544

Wayne, we would love to hear from you! If you would like a near term meeting that could be spicy, the oncologics ac will meet 9/10 or 9/11 to consider idec's Zevalin. Probably be some Corixa reps in the audience too. As for the public hearing being complete, there is sometimes a closed door session; for example, from the Pink Sheet: Aviron FluMist Release Tests In Human Subjects may be required in order to ensure attenuation before each flu season. Company confident of 2002 launch following vaccine committee closed-door session on FluMist manufacturing, Chief Executive says. Questions about vaccine's association with pneumonia linger for some on committee. Wilder